Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ribosomal protein L7a pseudogene 9 (RPL7AP9) is a non-functional, processed pseudogene related to the ribosomal protein L7a gene. Pseudogenes like RPL7AP9 are DNA sequences that arise from duplication or retrotransposition of genes, but accumulate mutations and typically do not encode functional proteins. While the canonical RPL7A gene is a structural constituent of the ribosome and is essential for protein synthesis[1][3], its pseudogenes—including RPL7AP9—are not involved in ribosomal function or known cellular pathways and hold no direct therapeutic significance. "RPL7AP9" is often listed with commercial reagents for gene knockdown, but the knockdown of this pseudogene would not affect ribosomal function, as it is not translated[4][6]. Disease roles, interacting drugs, and mechanisms cited for "RPL7A" do not apply to "RPL7AP9"[3]. The presence of multiple pseudogenes for ribosomal protein genes in the genome is a common feature, but only the functional gene (RPL7A) is of biological and therapeutic interest[1][3]. In summary, RPL7AP9 is not a valid therapeutic target; it is a processed pseudogene, not a functional receptor, enzyme, or transporter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ribosomal protein L7a pseudogene 9 (RPL7AP9).